Market Place
Sourcing Support
MediPharm Labs acquires advanced cannabis delivery method technology
24 Jun 2024 //
INDIANPHARMAPOST
MediPharm Achieves Pharma GMP Certification with Brazilian Health Authority
07 Feb 2024 //
PR NEWSWIRE
DKSH Acquires Healthcare Distributor Medipharm in Brunei
15 Jan 2024 //
PRESS RELEASE
MediPharm Labs Provides Update on Board of Directors and Incentive Program
22 Dec 2023 //
PR NEWSWIRE
MediPharm Labs Sets Date to Report Third Quarter 2023 Financial Results
08 Nov 2023 //
PR NEWSWIRE
MediPharm Labs Settles an Outstanding Claim for $9M
02 Oct 2023 //
PRESS RELEASE
MediPharm Labs Launches New GMP Products to the Australian Medical Cannabis Market
27 Sep 2023 //
PRESS RELEASE
MediPharm Labs Improves Domestic Sales Gross Margin with Termination of Shelter Cannabis Brands Royalty Agreement
20 Sep 2023 //
PRESS RELEASE
MediPharm Labs Reports Second Quarter Results with Doubling of Revenue and Record Margin Growth
14 Sep 2023 //
PRESS RELEASE
MediPharm Welcomes News from the U.S. Government
07 Sep 2023 //
PRESS RELEASE
MediPharm Labs Completes Sale of Vacant Land for Cash Proceeds of $1.9 million
05 Sep 2023 //
PR NEWSWIRE
MediPharm Labs Sets Date to Report Second Quarter 2023 Financial Results
10 Aug 2023 //
PR NEWSWIRE
MediPharm Labs Makes First Delivery of Cannabis Clinical Trial Material
01 Aug 2023 //
PR NEWSWIRE
Avicanna and Medipharm Labs Expand Strategic Manufacturing Agreement
26 Jun 2023 //
GLOBENEWSWIRE
MediPharm Labs Reports First Quarter Results with Growth in Sales, Margin and EBITDA
15 May 2023 //
PRESS RELEASE
MediPharm Labs Sets Date to Report First Quarter 2023 Financial Results
10 May 2023 //
PRESS RELEASE
MediPharm Labs Provides Update on VIVO Integration and Board Appointee
13 Apr 2023 //
PRESS RELEASE
MediPharm Labs Corp. Completes Acquisition of VIVO Cannabis Inc. and Confirms Final Ownership Ratio
03 Apr 2023 //
PRESS RELEASE
MediPharm Labs Reports Fourth Quarter and Full Year 2022 Results
31 Mar 2023 //
PRESS RELEASE
MediPharm Labs Provides Update on Clinical Trial Progress
01 Mar 2023 //
PR NEWSWIRE
MediPharm Announces Mailing&Filing of Joint Circular for Meeting of Shareholders
21 Feb 2023 //
NEWSWIRE
MediPharm Labs Corp. to Acquire VIVO Cannabis Inc.
20 Dec 2022 //
NEWSWIRE
MediPharm Labs Receives Award for CBD Brand of the Year
08 Dec 2022 //
PR NEWSWIRE
MediPharm Labs Reports Third Quarter Results
14 Nov 2022 //
PR NEWSWIRE
MediPharm Labs Sets Date to Report Third Quarter 2022 Financial Results
09 Nov 2022 //
PRESS RELEASE
MediPharm Labs Completes Sale of Australian Facility for Proceeds of $7,250,000 AUD
07 Oct 2022 //
PRESS RELEASE
MediPharm Labs Sets Date to Report Second Quarter 2022 Financial Results
31 Aug 2022 //
PRESS RELEASE
MediPharm Labs Reports Second Quarter Results
15 Aug 2022 //
PRNEWSWIRE
MediPharm Labs Enters Cannabis Research Agreement with Keck School of Medicine of USC
09 Aug 2022 //
PRESS RELEASE
MediPharm Labs Awarded Payment of $9.8M in Connection to a 2020 Statement of Claim Against a Previous Customer
27 Jul 2022 //
PRESS RELEASE
MediPharm Enters into $6.2M Purchase Agreement for Sale Australian Facility
11 Jul 2022 //
PRESS RELEASE
MediPharm Labs Announces Voting Results From the 2022 Annual Meeting
30 Jun 2022 //
PRESS RELEASE
MediPharm Labs Reports First Quarter Results
16 May 2022 //
PRESS RELEASE
MediPharm Labs Sets Date to Report First Quarter 2022 Financial Results
12 May 2022 //
PRNEWSWIRE
MediPharm Names Experienced Pharma and Med Tech Executive David Pidduck, CEO
20 Apr 2022 //
PR NEWSWIRE
MediPharm Labs Continues to Lead with Innovation
05 Apr 2022 //
PRNEWSWIRE
MediPharm Labs Reports Fourth Quarter and Full Year 2021 Results
31 Mar 2022 //
PRESS RELEASE
MediPharm Sets Date to Report Q4 and Full Year 2021 Financial Results
29 Mar 2022 //
PRNEWSWIRE
MediPharm Strengthens Recreational Business Adding Flower&Pre-Rolls to Portfolio
22 Mar 2022 //
PR NEWSWIRE
MediPharm Enters United States Pharma Market with Submission of FDA DMF
23 Feb 2022 //
GLOBENEWSWIRE
MediPharm Labs Completes Payment of All Convertible Debt
05 Jan 2022 //
GLOBENEWSWIRE
MediPharm Labs Receives Award for CBD Brand of the Year
22 Dec 2021 //
GLOBENEWSWIRE
MediPharm Labs Provides Operational Update and Confirms Profitability
21 Dec 2021 //
GLOBENEWSWIRE
MediPharm Labs Announces Changes to Board of Directors
07 Dec 2021 //
GLOBENEWSWIRE
MediPharm Labs Completes Medical Cannabis Export to Barbados
25 Nov 2021 //
GLOBENEWSWIRE
MediPharm Labs Expands CBN Portfolio with Two New Products
23 Nov 2021 //
GLOBENEWSWIRE
MediPharm Labs Appoints New Chief Executive Officer
25 Oct 2021 //
GLOBENEWSWIRE
Insomnia Study using MediPharm`s CBD50 to Proceed to PII with Health Canada nod
31 Aug 2021 //
GLOBENEWSWIRE
MediPharm Labs Receives Govt. Grant to Assist with International Expansion
19 Aug 2021 //
GLOBENEWSWIRE
MediPharm Labs Receives Export Authorization to Ship Medical Cannabis to Brazil
18 Aug 2021 //
GLOBENEWSWIRE
MediPharm Reports Second Quarter 2021 Results and Pharmaceutical Strategy
16 Aug 2021 //
GLOBENEWSWIRE
MediPharm Labs Sets Date to Report Second Quarter 2021 Financial Results
10 Aug 2021 //
GLOBENEWSWIRE
MediPharm Labs Sets Date to Report Second Quarter 2021 Financial Results
10 Aug 2021 //
GLOBENEWSWIRE
MediPharm Labs Receives Canadian GMP Pharmaceutical DEL
15 Jul 2021 //
CONTRACT PHARMA
MediPharm Labs Receives Canadian GMP Pharmaceutical Drug Establishment Licence
14 Jul 2021 //
GLOBENEWSWIRE
MediPharm Labs Enters Research Agreement with McMaster University
21 Jun 2021 //
GLOBENEWSWIRE
European Pharmaceutical Company STADA and MediPharm Labs Begin First Sales
01 Apr 2021 //
GLOBENEWSWIRE
MediPharm Labs Receives Milestone Cannabis Drug Licence to Manufacture
17 Feb 2021 //
GLOBENEWSWIRE
MediPharm Labs Initiates Clinical Trial for Use of Cannabis
19 Oct 2020 //
GLOBENEWSWIRE
